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a b s t r a c t
Background: Catheter ablation (CA) is an established therapy for atrial ﬁbrillation (AF). However, the
assessment of anatomical information and predictors of AF recurrence remain unclear. We investigated
the relationship between anatomical information on the left atrium (LA) and pulmonary veins (PVs) from
three-dimensional computed tomography images and the recurrence of AF after CA.
Methods: Sixty-seven consecutive AF patients (mean age: 62710 years, median AF history: 42 (12; 60)
months, mean LA size: 4177 mm, paroxysmal: 56%) underwent CA and were followed for 19710
months. The segmented surface areas (antral, posterior, septal, and lateral) and dimensions (between the
anterior and posterior walls, the right inferior PV and mitral annulus [MA], the right superior PV and MA,
the left superior PV and MA, and the mitral isthmus) of the LA were evaluated three dimensionally using
the NavX system. The cross-sectional areas of the PVs were also evaluated.
Results: After the follow-up period, 49 patients (73%) remained free from AF. A multivariate analysis showed
that the diameter of the mitral isthmus and cross-sectional area of the right upper PV were associated with AF
recurrence (odds ratio: 1.070, CI: 1.02–1.12, p¼0.001; odds ratio: 0.41, CI: 0.21–0.77, p¼0.006).
Conclusion: Enlargement of the mitral isthmus and a smaller right superior PV cross-sectional area were
associated with AF recurrence.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Catheter ablation (CA) is a curative treatment option for
patients with atrial ﬁbrillation (AF) [1–3]. Reported rates of
recurrence following pulmonary vein isolation (PVI) vary accord-
ing to AF type, lesion concept, operator experience, technical
equipment used, and the quality of follow-up [4–8]. Over the past
two decades, the procedure has evolved from the ablation of focal
AF triggers inside the pulmonary veins (PVs) to wide-area circum-
ferential PV antrum isolation (PVAI) [4,5]. Data concerning the
predictors of AF recurrence are limited. In particular, anatomical
predictors as assessed by three-dimensional computed tomogra-
phy (3D-CT) imaging are not well established [9–12]. In the
present study, we sought to determine whether anatomical vari-
ables of the left atrium (LA) and PVs assessed by 3D-CT imaging
were associated with the recurrence of AF after CA.
2. Materials and methods
2.1. Patient selection
This study enrolled 67 consecutive patients with highly symp-
tomatic, medically refractory AF who had been treated with CA.
Paroxysmal AF was deﬁned as self-terminating AF of o1 week in
duration. The exclusion criteria were as follows: (1) signiﬁcant
renal dysfunction and/or heart failure and (2) AF ablation per-
formed without image integration.
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2.2. Ablation procedure and procedural endpoint
Prior to the procedure, transesophageal echocardiography was
performed to exclude thrombus formation. Patients were studied
under deep propofol or dexmedetomidine sedation while breathing
spontaneously. Unfractionated heparin was administered in bolus
form before the transseptal puncture to maintain an activated
clotting time 4300 s. In case of AF, internal electrical cardioversion
was performed to restore sinus rhythm. Mapping and ablation were
performed under the guidance of a NavX system (St. Jude Medical,
Inc.) after the integration of a three-dimensional (3D) model of LA
and PV anatomy obtained from a pre-interventional CT. Prior to the
ablation, the ablation catheter (IBI Therapy Cooled Path, St. Jude
Medical, Inc.) and reconstructed LA posterior anatomies were
aligned with the CT image [13]. A radiofrequency (RF) alternating
current was delivered in the unipolar mode between the irrigated
tip electrode of the ablation catheter and an external back-plate
electrode. The initial RF generator settings were: an upper catheter
tip temperature of 43 1C, maximal RF power of 30W, and an
irrigation ﬂow rate of 13 ml/min. During RF applications to the
posterior wall, the maximal RF power was initially set to 20W. All
patients underwent PVI. RF applications could be performed in a
‘point-by-point’ manner. The maximum time at the anterior and
posterior walls was 40 and 20 s, respectively. When ablating the
posterior wall, RF energy was routinely reduced by 10 W according
to the esophageal temperature measured with an esophageal
temperature probe (SensiTherm, St. Jude Medical). If the esophageal
temperature exceeded 39 1C, the ablation was stopped immediately
and the energy reduced further. Once the esophageal temperature
decreased to the normal range (37 1C), RF application was resumed.
If ablation could not be performed with 20Wof power, the line was
placed either more antrally or closer to the PV, depending on
individual anatomical ﬁndings. Catheter navigation was carried out
using a steerable sheath (Agilis, St. Jude Medical) [14].
The procedural endpoint was the electrophysiologically proven
bidirectional block of the PV-encircling ablation lines conﬁrmed
with a circular mapping catheter (Optima, St. Jude Medical). After
proving the bidirectional block of the PVs, we executed a stimula-
tion protocol (burst pacing from the coronary sinus at 300 ms,
250 ms, and 200 ms for 10 s each) to test inducibility. If AF was
induced, the patient was cardioverted and the procedure ended.
Pharmacological testing (high dose isoproterenol infusion: 20 mg/
min) was performed to identify non-PV triggers. If an AF trigger
from the superior vena cava (SVC) was documented, SVC isolation
was performed. Ablation of the cavotricuspid isthmus or linear
lesion was performed if a typical right atrial ﬂutter or macro-
reentrant atrial ﬂutter were induced by burst pacing, respectively.
Proton pump inhibitors were started at admission and continued
for 4 weeks, and esophagoscopy was repeated after 3–4 days if
mucosal ulcerations 410 mm were observed initially [15–17].
2.3. Measurement of anatomical parameters by 3D-CT
Preoperative CT data were transferred to the NavX system for
analysis. The following variables were measured using the NavX
Verismo software: the segmented surface area of the LA (cm2) (the
antral, posterior, septal, and lateral areas, left-sided antrum, and
right-sided antrum); cross-sectional PV area (cm2) (left superior
PV [LSPV], left inferior PV [LIPV], right superior PV [RSPV], right
inferior PV [RIPV]); LA dimensions (mm) (distance between the
anterior and posterior walls, the RSPV and mitral annulus [MA],
the RIPV and MA, the LSPV and MA, and the LIPV and MA) (Fig. 1).
Patients with a common left PV and/or right middle PV were
excluded from this NavX systemmeasurement. The cross-sectional
areas of the PVs were measured at the “ostium” level. The PV
ostiumwas deﬁned as the point of maximal inﬂection between the
PV wall and the LA wall. As described in a previous report, the
NavX system automatically calculates the PV cross-sectional area
using a manually selected PV ostium. The distance between the
PVs and MA was deﬁned as the shortest distance between the
selected point of the PV ostium and the MA.
2.4. Follow-up
Anti-arrhythmic treatment was discontinued post-interventionally
and beta-blockers were administered to all patients. After treatment,
patients received oral anticoagulation for 6 months (target INR:
2.0–3.0) or longer, depending on individual stroke risk as assessed
Fig. 1. Anatomical variables assessed by the NavX Verismo. The yellow, light blue, orange, green, purple, and blue areas indicate, respectively, the surface areas of the septal
wall, posterior wall, inferior wall, lateral wall, left-sided antrum, and right-sided antrum. The red, orange, green, and light blue lines indicate, respectively, the distances
between the LIPV and MA, the RIPV and MA, the RSPV and MA, and the LSPV and MA. The blue, red, brown, and light brown areas indicate, respectively, the cross-sectional
areas of the LSPV, LIPV, RSPV, and RIPV. LA¼ left atrium, LSPV¼ left superior pulmonary vein, LIPV¼ left inferior pulmonary vein, RSPV¼right superior pulmonary vein,
RIPV¼right inferior pulmonary vein, MA¼mitral annulus.
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using the CHADS2 score. In all patients, 24-h Holter electrocardiograms
(SCM-6600; Fukuda Denshi) were obtained after 3, 6, 12, 24, and 36
months. If symptoms occurred outside the recording period, patients
were asked to contact our center or the referring physician to obtain
ECG documentation. AF and/or any atrial tachycardia (AT) episodes
lasting longer than 30 s were considered recurrences.
2.5. Statistics
The data were evaluated using the Kolmogorov–Smirnov test
and are presented as the mean7standard deviation for normally
distributed variables. Medians and quartiles are given for non-
normally distributed variables. Categorical variables are expressed
as numbers and percentages. Cox proportional hazards regression
models were used to estimate hazard ratios and 95% conﬁdence
intervals for AF/AT recurrence. Receiver operating characteristic
curves were used to determine the cross-sectional RSPV area (c-
RSPV) and distance between the LIPV and MA (d-LIPV–MA) that
provided optimal sensitivities and speciﬁcities for the elimination
of AT and AF recurrence after a single PVAI procedure. The analysis
prioritized speciﬁcity rather than sensitivity. Regarding the rela-
tive cost of false positive and false negative results, a false positive
result of o10%, indicating AF and AT recurrences despite a c-RSPV
greater than the cutoff value, was considered an optimal cutoff for
the c-RSPV. Meanwhile, a false positive result of o10%, indicating
freedom from AF and AT recurrences despite a d-LIPV–MA greater
than the cutoff value, was considered an optimal cutoff for the
d-LIPV–MA. Freedom from AF and AT was determined using the
Kaplan–Meier method. A survival analysis grouped by isolated
surface area was performed using a log-rank test. The variables in
the multivariable Cox proportional hazards regression model
included the cross-sectional areas of the LSPV and RSPV and the
d-LIPV–MA, which had a p-value o0.05 in the univariate Cox
proportional hazard regression analysis. A p-value o0.05 was
considered statistically signiﬁcant. All statistical analyses were
performed with SPSS, Release 11.0.
3. Results
3.1. Patient characteristics and rhythm outcome
Patient characteristics are displayed in Table 1. A total of 67
patients with symptomatic AF and a median AF history of 42
months (1st–3rd quartile, 12–60) were included. The mean patient
age was 62710 years, 48 patients (72%) were male, the mean LA
diameter was 4177 mm, and the mean left ventricular ejection
fraction (LVEF) was 61710%. The cohort included 32 (52%)
patients with hypertension and 1 (1%) with coronary artery
disease. During a follow-up period of 19710 months, 49 (73%)
patients remained free from AF. Of the 18 patients who suffered a
recurrence, AF was documented in 17 patients and roof-dependent
AT was documented in one patient. A univariate Cox proportional
hazard regression analysis revealed no statistically signiﬁcant
differences in any patient characteristics except hypertension
between patients with and without arrhythmia recurrences
(Table 2).
3.2. Procedural parameters and rhythm outcome
Table 3 summarizes the procedural parameters and rhythm
outcomes. Ablation of the cavotricuspid isthmus was previously
performed in 2 patients (3%). Ablation was performed by 6 experi-
enced electrophysiologists. Complete PVAI was achieved in all
patients. Isolation of the SVC and linear ablation were performed
in 7 and 9 patients, respectively. Complete SVC isolation was
achieved in all patients. Early AF recurrence was strongly associated
with AF recurrence (odds ratio: 5.10, CI: 1.96–13.2, p¼0.001). A
univariate Cox proportional hazard regression analysis revealed no
statistically signiﬁcant differences in any procedural parameters
except for early recurrence between patients with and without
arrhythmia recurrences. A 2nd procedure was performed in 16
(89%) of the 18 patients with AF recurrence. LA–PV re-isolation and
additional ablation were performed in 13 and 14 patients, respec-





Male (n – %) 48 (72)
AF history (months) 42 (12; 60)
Persistent AF (n – %) 21 (31)
Antiarrhythmic drugs (n) 1.271.0
Arterial hypertension (n – %) 35 (52)
Coronary artery disease (n – %) 1 (1)
Diabetes mellitus (n – %) 8 (12)
Lone AF (n – %) 25 (37)
Left atrial diameter (mm) 4177
LV ejection fraction (%) 61710
Prior CTI ablation (n – %) 2 (3)
Left common pulmonary vein (n – %) 3 (4)
Right middle pulmonary vein (n – %) 9 (13)
AF¼atrial ﬁbrillation, LV¼ left ventricle, CTI¼cavotricuspid isthmus.
Table 2
Patient characteristics associated with AF recurrence.
Univariate
Unadjusted OR CI 95% p Value
Age 1.01 0.97–1.06 0.61
Male 0.77 0.29–2.06 0.60
AF history 1.00 1.00–1.01 0.30
Antiarrhythmic drugs 0.97 0.60–1.56 0.90
Arterial hypertension 2.76 0.99–7.74 0.05
Coronary artery disease – – –
Diabetes mellitus 0.92 0.21–3.99 0.91
Lone AF 0.87 0.32–2.55 0.79
Persistent AF 1.50 0.58–3.88 0.39
Left atrial diameter 1.03 0.96–1.11 0.37
LV ejection fraction 0.99 0.95–1.03 0.62
Prior CTI ablation – – –
Left common pulmonary vein – – –
Right middle pulmonary vein 0.83 0.19–3.60 0.79
Additional ablation 0.64 0.08–4.71 0.65
AF inducible 1.02 0.39–2.63 0.97
AF¼atrial ﬁbrillation, LV¼ left ventricle, CTI¼cavotricuspid isthmus.
Table 3
Procedural parameters associated with AF recurrence.
Univariate
Unadjusted OR CI 95% p Value
Early recurrence 5.10 1.96–13.2 0.001
Arrhythmogenic PV 0.58 0.22–1.47 0.24
APC from extra PV 1.37 0.52–3.67 0.52
SVC isolation 1.00 0.30–4.33 1.00
Linear ablation 0.63 0.43–5.13 0.53
AF¼atrial ﬁbrillation, PV¼pulmonary vein, APC¼atrial premature contraction.
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modiﬁcation and/or non-PV foci ablation to achieve the procedural
endpoints.
3.3. Topographic variability and rhythm outcome
Regarding abnormal PV anatomy, 3 of the 67 patients (4%) had
a left common pulmonary vein (LCPV) and 9 (13%) had a right
middle pulmonary vein (RMPV). The presence of an LCPV or RMPV
was not associated with AF recurrence (Table 2). A univariate Cox
proportional hazard regression analysis identiﬁed three anatomi-
cal parameters related to AF and/or AT recurrence: the d-LIPV–MA,
the distance between the RIPV and MA, and the c-RSPV. In the
multivariate Cox proportional hazard regression analysis, the
predictive model of AF and/or AT recurrence consisted of the
d-LIPV–MA and c-RSVP (odds ratio: 1.07, CI: 1.02–1.12, p¼0.001;
odds ratio: 0.42, CI: 0.21–0.77, p¼0.006, Table 4). Fig. 2 shows
representative cases with and without AF recurrence.
3.4. Optimal cutoff values of c-RSPV and d-LIPV–MA associated with
rhythm outcomes
A receiver operating characteristic curve analysis yielded an
optimal cutoff value of 2.9 cm2 for the c-RSPV and 39mm for the
d-LIPV–MA. The sensitivity and speciﬁcity associated with AF freedom
at the c-RSPV cutoff value were 49% and 83%, respectively. The
sensitivity and speciﬁcity associated with AF recurrence at the
d-LIPV–MA cutoff value were 56% and 89%, respectively. A Kaplan–
Meier curve revealed that the rate of freedom from AF and macro-
reentrant tachycardia recurrences after a single procedure was 89% in
patients with a larger c-RSPV (42.9 cm2) and 63% in patients with a
smaller c-RSPV (o2.9 cm2) (log-rank test, p¼0.014, Fig. 3A). The rate
of freedom from AF was 38% in patients with a longer d-LIPV–MA
(439mm) and 84% in patients with a shorter d-LIPV–MA (o39mm)
(log-rank test, p¼0.0002, Fig. 3B).
4. Discussion
4.1. Main ﬁndings
The present study demonstrated associations of the d-LIPV–MA
and c-RSPV with AF and/or AT recurrence after a single AF
procedure. For every 1-mm increase, the d-LIPV–MA was asso-
ciated with a 7.0% increase in the probability of AF and/or AT
recurrence. For every 1 cm2 increase, the c-RSPV was associated
with a 59% decrease in the probability of AF and/or AT recurrence.
4.2. Conventional parameters associated with AF recurrence
AF and/or AT recurred in 18 (27%) of the 67 patients after the
ﬁrst AF ablation procedure. A Cox univariate hazard regression
analysis performed during the follow-up period identiﬁed no
procedural parameters or patient characteristics with the excep-
tion of early recurrence and hypertension. Previous studies
reported that age, gender, LVEF, LA size, LA volume, structural
heart disease, AF duration, and abnormal pulmonary vein anatomy
could predict recurrence [18]. In the current study, however, these
parameters were not associated with AF recurrence This discre-
pancy may be related to the heterogeneity of AF ablation strategies
and to differences in study inclusion criteria. In addition, most of
the studies performed a multivariate analysis using multiple
logistic regression. No survival analyses were performed [19].
4.3. The d-LIPV–MA in association with AF and/or AT recurrence
LA enlargement as assessed by echocardiography was not a
reliable predictor of recurrence according to several multivariate
analyses [18–21]. This may be related to inter-observer variations in
LA assessment and to the absence of any deﬁned criteria for an LA
enlargement evaluation by echo studies. By contrast, our measure-
ment of the d-LIPV–MAwas performed on a 3D-CT image that could
be segmented by the NavX system's NavX Verismo software. In a
previous study, we reported excellent inter- and intra-variability for
anatomical measurements of both the LA and PVs [8]. In brief, there
was excellent correlation between the observers and between the
initial and second calculations (inter-observer correlations, respec-
tively: r¼0.97, po0.001; r¼0.96, po0.001; r¼0.85, po0.001;
intra-observer correlations, respectively: r¼0.99, po0.001; r¼0.99,
po0.001; r¼0.97, po0.001). This suggests that both the inter- and
intra-observer variabilities were within an acceptable range as
compared to echocardiography measurements. McGann et al.
reported that atrial ﬁbrosis assessed by delayed enhancement
magnetic resonance imaging (DE-MRI) was associated with a poor
response to CA therapy for AF [22–24]. They concluded that patients
with a 430% enhancement on MRI showed a poor procedure
outcome with a 470% failure rate. Interestingly, the localization of
the atrial ﬁbrosis was likely the LA bottom as well as the LA posterior
wall. Considering the organs surrounding the LA, the LA bottom was
likely to be more easily enlarged compared to the LA posterior wall.
The enlargement of the LA posterior wall was limited by the PVs at
the corners of the posterior wall and by the pulmonary artery at the
roof of the posterior wall. Of note, posterior wall extension was likely
limited by the descending aortic artery and spine, whereas the
enlargement of the LA bottom was not limited by any surrounding
organs. Thus, the d-LIPV–MA may reﬂect the degree of structural
remodeling including atrial ﬁbrosis induced by AF as compared to the
conventional LA anterior–posterior diameter. Bisbal et al. reported
that the LA remodeling process associated with AF leads to spherical
deformation of the LA and that LA sphericity, a measure of spherical
remodeling, is an independent and strong predictor of AF ablation
success [25]. Notably, this deformation may induce enlargement of
the LA bottom. This ﬁnding is likely consistent with our results.
Table 4















Posterior area 0.97 0.79–1.18 0.73
Inferior area 1.08 0.99–1.17 0.07
Septal area 1.05 0.99–1.11 0.12
Lateral area 1.07 0.94–1.23 0.31
Dimensions of the LA
AP 1.03 0.96–1.12 0.41
RIPV-MA 1.11 1.03–1.19 0.006 1.07 1.00–1.15 0.06
RSPV–MA 1.03 0.98–1.09 0.23
LSPV–MA 1.02 0.98–1.06 0.42
LIPV–MA 1.10 1.04–1.16 o0.001 1.07 1.02–1.12 0.01
Cross-sectional areas of the PV
LSPV 0.70 0.37–1.32 0.27
LIPV 0.64 0.31–1.33 0.23
RSPV 0.39 0.20–0.76 0.006 0.41 0.21–0.77 0.006
RIPV 0.58 0.30–1.11 1.00
AF¼atrial ﬁbrillation, LA¼ left atrium, AP¼anterior–posterior, RIPV¼right inferior
pulmonary vein, RSPV¼right superior pulmonary vein, LSPV¼ left superior pul-
monary vein, LIPV¼ left inferior pulmonary vein, MA¼mitral annulus.
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4.4. The c-RSPV in association with AF and/or AT recurrence
Regarding PV anatomy, the presence of an LCPV or RMPV has
been reported to be associated with increased freedom from AF
ablation [26,27]. It was speculated that an LCPV could facilitate
greater contact force along the left PV–left atrial appendage (LAA)
ridge and would not interfere with the CA, and that the minimal
risk of PV stenosis would allow for a slightly deeper ablation of the
venous aspect of the left PV–LAA ridge. LCPVs may also more
frequently harbor triggers responsible for AF episodes. In the
current study, an LCPV and RMPV were reported in only 4% and
13% of patients, respectively. Therefore, we could not evaluate the
Fig. 2. Representative cases with and without AF recurrence. (A) Representative case without AF recurrence. (B) Representative case with AF recurrence. In contrast to the
patient with AF recurrence, a shorter distance between the LIPV and MA and a larger cross-sectional RSPV area were observed in the patient without AF recurrence.
AF¼atrial ﬁbrillation, LIPV¼ left inferior pulmonary vein, RSPV¼right superior pulmonary vein.
Fig. 3. A Kaplan–Meier curve of freedom from AF according to anatomical parameters. (A) A comparison of freedom from AF recurrence between patients with and without
an RSPV with a cross-sectional area greater than 2.9 cm2. (B) A comparison of freedom from AF recurrence between patients with and without a distance shorter than 39 mm
between the LIPV and MA.
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relationship between PV anatomy and AF recurrence with statis-
tical power. Of note, larger LSPV and RSPV cross-sectional areas
were associated with AF recurrence in the univariate Cox hazard
model. This indicated that the anatomical and arrhythmogenic
properties of an LSPV with a large cross-sectional area were
similar to those of an LCPV. Uijl et al. investigated the effects of
LA dimensions, PV dimensions, and PV anatomy on AF ablation
outcomes in a similar patient population (72% in paroxysmal AF,
28% in persistent AF). They concluded that an enlargement of the
anteroposterior LA diameter and normal right PV anatomy were
independent risk factors for AF recurrence [28]. No relationship
was found between PV dimensions and the outcome of AF
ablation. We speculated that a dilated PV might stretch the
myocardial sleeve within the PV, which could induce arrhythmo-
genicity. Thus, the impact of a complete PVI is likely greater in
patients with a dilated PV. The spine and pulmonary artery, with
respective locations behind the inferior PVs and over the LSPV,
may limit PV dilatation. By contrast, the SVC is located in the
anterior part of the RSPV. No organs are located over or behind the
RSPV, which may facilitate the easy dilatation of the RSPV as
compared to other PVs. We considered that a different evaluation
of the dilated PV may yield a contradictory outcome. The PV may
be dilated three-dimensionally but not equally in the superior–
inferior and anterior–posterior directions. In the present study, we
evaluated the degree of PV dilatation by measuring the cross-
sectional area of the PV. This three-dimensional measurement
may evaluate the degree of PV dilatation more precisely as
compared to the conventional two-dimensional measurement.
4.5. Clinical implications
The current study identiﬁed two novel anatomical predictors of
AF recurrence after a single AF ablation: (1) a long d-LIPV–MA and
(2) a small c-RSPV. The recommended cutoff values were 39 mm
for the d-LIPV–MA and 2.9 cm2 for the c-RSPV. These two
anatomical parameters can be easily determined using 3D-CT
prior to the procedure. When considering patient selection for
AF ablation or a more aggressive AF strategy, the observation of an
enlarged LA bottom and/or small PVs constituted very useful
anatomical information.
4.6. Study limitations
Our study had two major limitations. First, the sample size was
relatively small. Second, this study was nonrandomized and not
designed to clearly compare procedural outcomes with those
obtained by other methods. Our ﬁndings should therefore be
veriﬁed in a randomized prospective study.
5. Conclusions
A long d-LIPV–MA and small c-RSPV were associated with AF
recurrence after a single AF ablation procedure. Three-dimensional
assessment of both the LA and PV anatomies is useful for selecting
patients suitable for AF ablation or a more aggressive AF ablation
procedure.
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